Related Experiment Video
Updated: Aug 12, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
[Vitamin E in active arthroses and chronic polyarthritis. What is the value of alpha-tocopherol in therapy?]
Abstract:
Known and recognized mechanisms of action of alpha-tocopherols are the grounds for the use of vitamin E in activated arthrosis or rheumatoid arthritis. This is also supported by the positive clinical results obtained in double-blind studies. On this basis, a change in the evaluation of these substances has taken place in recent years. Initially characterised as "unorthodox", "unconventional" or "additive" therapy, the term now applied tends to be "adjuvant-accepted" therapy. The results of double-blind studies and clinical empiricism support the following hyperthesis: The pathogenetic substrate "free oxygen radicals" increases quantitatively from activated arthrosis to (bland, mild) chronic polyarthritis. This could explain the graded differentiated antioxidative (or hypothetically the "central-analgesic") effects of alpha-tocopherols. While there still is no causal treatment with the alpha-tocopherols-pain alleviation and anti-inflammatory effect-are similar to those achieved with non-steroidal antiinflammatory drugs, the potency of which, however, is superior.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
08:32A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
Published on: March 20, 2026
Related Concept Videos
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Rheumatic Heart Disease III: Medical Management
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management